Omaxe Stock Screener | Share Price & Fundamental Analysis
OMAXE
Residential Commercial Projects
Share Price NSE
₹77.13
▲
0.02 (0.03%)
Share Price BSE
₹76.90
▼
-0.42 (-0.54%)
As of April 13, 2026, the Omaxe share price (NSE: OMAXE) is ₹77.13 on NSE and ₹76.90 on BSE, up 0.03% from the previous close, with shares trading between ₹74.31 and ₹78.00, and a 52-week range of ₹64.09–₹106.91.
Browse OMAXE quarterly financials to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Omaxe Market Cap
₹1,337.73 Cr.
OMAXE P/E Ratio (TTM)
-1.92
Omaxe P/B Ratio
-2.25
EPS (TTM)
₹-37.51
Dividend Yield
-
Debt to Equity
2.54
OMAXE 52 Week High
₹106.91
Omaxe 52 Week Low
₹64.09
Operating Margin
-51.00%
Profit Margin
-47.96%
OMAXE Revenue (TTM)
₹319.00
EBITDA
₹-138.00
Net Income
₹-153.00
Total Assets
₹14,877.00
Total Equity
₹-196.00
Omaxe Share Price History - Stock Screener Chart
Screen OMAXE historical share price movements with interactive charts. Analyze price trends and patterns.
Omaxe Company Profile - Fundamental Screener
Screen Omaxe company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for OMAXE shares.
Sector
Realty
Industry
Residential Commercial Projects
Sub-Sector
Residential Commercial Projects
Segment
E
ISIN
INE800H01010
Omaxe Balance Sheet Screener
Screen OMAXE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14,877 | 13,822 | 13,560 | 11,918 | 11,042 | 10,549 | 10,760 | 8,128 | 8,326 | 7,712 |
| Current Assets | 13,260 | 12,458 | 12,298 | 10,735 | 9,889 | 9,366 | 9,620 | 7,250 | 7,283 | 6,652 |
| Fixed Assets | 606 | 565 | 582 | 627 | 671 | 747 | 599 | 604 | 604 | 600 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,120 | 1,139 | 1,177 | 942 | 1,193 | 1,292 | 1,327 | 1,251 | 1,572 | 1,442 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -196 | 489 | 910 | 1,260 | 1,422 | 1,656 | 1,756 | 2,213 | 2,134 | 2,042 |
| Share Capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Reserves & Surplus | -613 | 72 | 490 | 837 | 997 | 1,231 | 1,332 | 1,789 | 1,711 | 1,848 |
Omaxe Income Statement Screener - Profit & Revenue Analysis
Screen Omaxe income statement and profit fundamentals.
Analyze OMAXE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Omaxe share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 319 | 346 | 298 | 553 | 300 | 398 | 385 | 543 | 602 | 270 | 221 | 298 | 254 | 122 | 124 |
| Expenses | 457 | 490 | 452 | 647 | 416 | 613 | 493 | 682 | 637 | 333 | 306 | 399 | 346 | 187 | 145 |
| EBITDA | -138 | -144 | -154 | -94 | -115 | -215 | -108 | -139 | -35 | -63 | -85 | -101 | -92 | -65 | -21 |
| Operating Profit % | -51.00% | -53.00% | -60.00% | -20.00% | -44.00% | -58.00% | -44.00% | -27.00% | -6.00% | -25.00% | -43.00% | -38.00% | -42.00% | -57.00% | -19.00% |
| Depreciation | 9 | 8 | 7 | 12 | 10 | 8 | 7 | 14 | 15 | 10 | 16 | 16 | 16 | 16 | 17 |
| Interest | 54 | 65 | 67 | 51 | 57 | 45 | 42 | 38 | 32 | 29 | 31 | 26 | 27 | 31 | 29 |
| Profit Before Tax | -201 | -217 | -228 | -157 | -183 | -267 | -157 | -191 | -82 | -103 | -132 | -143 | -136 | -112 | -66 |
| Tax | -48 | -50 | -42 | -9 | -32 | -27 | -10 | -48 | -10 | -18 | -25 | -38 | -27 | -25 | -16 |
| Net Profit | -153 | -166 | -186 | -149 | -150 | -240 | -147 | -144 | -72 | -84 | -106 | -104 | -109 | -87 | -50 |
| EPS | -8.38 | -9.11 | -10.16 | -8.11 | -8.23 | -13.10 | -8.06 | -7.93 | -3.66 | -4.61 | -5.81 | -5.77 | -5.79 | -4.78 | -2.68 |
Omaxe Cash Flow Screener - Liquidity Fundamentals
Screen OMAXE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,007 | 987 | 469 | 783 | 566 | 638 | 401 | 19 | 121 | 91 |
| Investing Activities | -126 | -64 | -142 | -22 | 23 | 106 | 16 | 21 | 20 | 7 |
| Financing Activities | -770 | -924 | -262 | -740 | -517 | -783 | -435 | -36 | -173 | -105 |
| Net Cash Flow | 111 | -1 | 65 | 21 | 72 | -39 | -18 | 4 | -32 | -7 |
Omaxe Shareholding Pattern Screener
See Omaxe shareholding pattern with promoter, FII, and DII holdings.
Check Omaxe promoter holding and ownership changes for OMAXE on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% |
| FII Holding | 7.38% | 6.66% | 6.06% | 5.11% | 7.09% | 7.12% | 7.19% | 7.27% |
| DII Holding | 2.29% | 2.26% | 1.56% | 1.56% | 2.39% | 2.29% | 2.29% | 2.29% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.17% | 11.21% | 12.23% | 14.18% | 11.26% | 11.01% | 11.22% | 11.21% |
| Other Holding | 5.02% | 5.73% | 6.01% | 5.00% | 5.11% | 5.44% | 5.16% | 5.09% |
| Shareholder Count | 48,385 | 48,598 | 49,331 | 48,463 | 51,810 | 50,864 | 49,450 | 48,084 |
Omaxe Share Dividend Screener - Share Yield Analysis
Check Omaxe dividend history with payout and yield data.
View Omaxe dividend details including ex-dates and amounts for OMAXE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.70 | 0.46% |
| 2018-March | ₹0.70 | 0.34% |
| 2017-March | ₹0.70 | 0.32% |
Omaxe Stock Index Membership
See which indices include Omaxe stock.
Check OMAXE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Omaxe Market Events Screener - Corporate Actions
Get Omaxe corporate actions including splits, bonuses, and buybacks.
Check Omaxe stock events that may affect OMAXE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.50% | ||
| Annual General Meeting | NA | -0.48% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 7.16% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.72% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -0.10% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 12.99% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -1.31% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.93% |
Omaxe Competitors Screener - Peer Comparison
Screen OMAXE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| DLF | 129,273 | 28.49 | 8,996 | 29.28% | 2,695 | 38.45 |
| Lodha Developers | 69,528 | 20.46 | 14,170 | 35.34% | 2,767 | 21.19 |
| Oberoi Realty | 54,791 | 23.99 | 5,474 | 13.60% | 2,226 | 53.69 |
| Phoenix Mills | 54,546 | 38.25 | 3,965 | -3.54% | 1,302 | 41.47 |
| Prestige Estates Projects | 49,620 | 46.68 | 7,736 | -17.93% | 617 | 31.82 |
| Godrej Properties | 45,431 | 28.89 | 6,967 | 60.74% | 1,389 | 38.68 |
| Brigade Enterprises | 16,817 | 20.99 | 5,314 | 4.92% | 681 | 50.65 |
| Anant Raj | 16,257 | 30.62 | 2,100 | 38.11% | 422 | 44.54 |
| Sobha | 12,370 | 89.88 | 4,163 | 29.36% | 95 | 29.32 |
| Signatureglobal | 10,531 | 3017.29 | 2,638 | 99.15% | 101 | 37.34 |
Omaxe Company Announcements - News Screener
Screen OMAXE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-04 | Closure of Trading Window | - |
| 2026-03-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-21 | Intimation With Respect To Project Launch And Regulatory Approvals | - |
| 2026-03-20 | Intimation With Respect To Project Launch And Regulatory Approval. | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-03-16 | Intimation With Respect To Project Launch And Regulatory Approvals | - |
| 2026-03-11 | Intimation With Respect To Project Launch And Regulatory Approvals. | - |
| 2026-03-06 | Intimation With Respect To Project Launch And Regulatory Approval | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-05 | Intimation With Respect To Project Launch And Regulatory Approval | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-02-18 | Intimation With Respect To Project Launch And Regulatory Approvals. | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Un-Audited Financial Results For Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-06 | Board Meeting Outcome for Outcome Of Board Meeting Of Omaxe Limited Held On February 06 2026. | - |
| 2026-02-05 | Intimation With Respect To Project Launch And Regulatory Approval. | - |
| 2026-01-30 | Closure of Trading Window | - |
| 2026-01-30 | Board Meeting Intimation for Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended On December 31 2025 And Other Matters. | - |